Targeted therapies in the management of Colorectal cancer

Targeted therapies in the management of Colorectal cancer

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Maughan, T
التنسيق:	Conference item
منشور في:	2011

مواد مشابهة

Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.
حسب: Adams, R, وآخرون
منشور في: (2007)

Colonoscopy, Biomarkers, and Targeted Therapy in Colorectal Cancer
حسب: Rustam Effendi-YS
منشور في: (2022-07-01)

Management of the asymptomatic primary in the palliative treatment of metastatic colorectal cancer.
حسب: Clements, D, وآخرون
منشور في: (2009)

CEA-targeted monoclonal antibody therapy in colorectal cancer
حسب: Conaghan, P, وآخرون
منشور في: (2009)

Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer
حسب: Patrick W. Underwood, وآخرون
منشور في: (2024-01-01)

The Effective Role of Targeted Therapy in Advanced Colorectal Cancer
حسب: Sarah K. Obay, وآخرون
منشور في: (2022-07-01)

Signaling pathways in colorectal cancer: implications for the target therapies
حسب: Yanlin Song, وآخرون
منشور في: (2024-06-01)

Progress of research on molecular targeted therapies for colorectal cancer
حسب: Shilin Huang, وآخرون
منشور في: (2023-08-01)

New developments in targeted therapy for metastatic colorectal cancer
حسب: Ambrose H. N. Wong, وآخرون
منشور في: (2023-01-01)

Targeted splicing therapy: new strategies for colorectal cancer
حسب: Yifeng Zheng, وآخرون
منشور في: (2023-08-01)

Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
حسب: Sun Weijing
منشور في: (2012-10-01)

Screening of potential molecular targets for colorectal cancer therapy
حسب: Kimi Honma, وآخرون
منشور في: (2009-11-01)

Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
حسب: Prashanth Rawla, وآخرون
منشور في: (2019-07-01)

Study on the Targeted Therapy of Colorectal Cancer with Multiple Pathway
حسب: Zhou Junheng
منشور في: (2024-01-01)

The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy
حسب: Abdo Meyiah, وآخرون
منشور في: (2025-03-01)

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
حسب: Adams, R, وآخرون
منشور في: (2008)

Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
حسب: Heng, Fong Seow, وآخرون
منشور في: (2016)

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
حسب: Qing Li, وآخرون
منشور في: (2024-10-01)

EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges
حسب: Balakarthikeyan Janani, وآخرون
منشور في: (2022-03-01)

Targeting VCP potentiates immune checkpoint therapy for colorectal cancer
حسب: Fang Wang, وآخرون
منشور في: (2023-11-01)

Strategy to targeting the immune resistance and novel therapy in colorectal cancer
حسب: Wang Gang, وآخرون
منشور في: (2018-05-01)

Effect of gut microbiota in the colorectal cancer and potential target therapy
حسب: Junchuan Li, وآخرون
منشور في: (2022-06-01)

The c-Met receptor: Implication for targeted therapies in colorectal cancer
حسب: Elmira Safaie Qamsari, وآخرون
منشور في: (2017-04-01)

Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models
حسب: Fortuné M. K. Elekonawo, وآخرون
منشور في: (2019-12-01)

Metastatic colorectal cancer-prolonging overall survival with targeted therapies
حسب: Satya Dattatreya
منشور في: (2013-01-01)

A pilot study of the use of Oxaliplatin in metastatic colorectal cancer at Velindre
حسب: Mitra, S, وآخرون
منشور في: (2001)

Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
حسب: Li Kuiyuan, وآخرون
منشور في: (2009-04-01)

Editorial: Molecular mechanisms and targeted therapies for colorectal cancer vol II
حسب: Alessandro Passardi, وآخرون
منشور في: (2025-02-01)

The challenge and opportunity of gut microbiota‐targeted nanomedicine for colorectal cancer therapy
حسب: Yaohua Wei, وآخرون
منشور في: (2024-08-01)

Clinical Application of Liquid Biopsy in Targeted Therapy of Metastatic Colorectal Cancer
حسب: Jörg Trojan, وآخرون
منشور في: (2017-01-01)

Focused Ultrasound as Targeted Therapy for Colorectal Cancer: A Comprehensive Review
حسب: Muhammad Awais Farooqi, وآخرون
منشور في: (2024-04-01)

Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches
حسب: Furong Li, وآخرون
منشور في: (2023-10-01)

Second-line targeted therapy for metastatic colorectal cancer. Possibilities for choices
حسب: L. V. Bolotina, وآخرون
منشور في: (2018-11-01)

Targeted drugs in the second line anticancer therapy of disseminated colorectal cancer
حسب: K. A. Vorontsova, وآخرون
منشور في: (2015-12-01)

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action
حسب: Lu Zhan, وآخرون
منشور في: (2023-08-01)

Antibody targeting of claudin-1 as a potential colorectal cancer therapy
حسب: S. Cherradi, وآخرون
منشور في: (2017-06-01)

Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies
حسب: Hull R, وآخرون
منشور في: (2020-10-01)

Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer
حسب: Tong Shen, وآخرون
منشور في: (2021-03-01)

Current targeted therapies in the treatment of advanced colorectal cancer: a review
حسب: Andrew Moriarity, وآخرون
منشور في: (2016-07-01)

Statin Treatment as a Targeted Therapy for APC-Mutated Colorectal Cancer
حسب: Hannah Shailes, وآخرون
منشور في: (2022-05-01)